Jaume Pons

Jaume Pons

Fundador en
Alx Oncology Ltd.
.

Fortuna: 939 966 $ al 31/05/2026

60 años
Health Technology
Consumer Services
Finance

Perfil

Jaume Pons is the founder of ALX Oncology Ltd., founded in 2015, serving as President, Chief Executive Officer & Director.
Dr. Pons was the founder of ALX Oncology Holdings, Inc., founded in 2015, serving as President & Chief Scientific Officer from 2024 to 2025.
Dr. Pons is also the founder of ALX Oncology, Inc.,Tallac Therapeutics, Inc...
Dr. Pons currently serves as Director at Alexo Therapeutics International and Sirpant Therapeutics.
Dr. Pons is Scientific Advisor at LSV Capital Management LLC.
Dr. Pons is Venture Partner at venBio Partners LLC since 2015.
Formerly, Dr. Pons was Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
Dr. Pons was Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed graduate studies at the University of California, Berkeley.
Dr. Pons completed undergraduate, graduate, and doctorate degrees at the Autonomous University of Barcelona.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 494.719 ( 0,37 % ) 939 966 $ 31/05/2026

Cargos activos de Jaume Pons

EmpresasCargoInicio
Inversor de Capital Privado 04/01/2015
Fundador 01/04/2015
Director/Miembro de la Junta -
Fundador -
Sirpant Therapeutics
Director/Miembro de la Junta -
Consultor / Asesor -

Antiguos cargos conocidos de Jaume Pons.

EmpresasCargoFin
ALX ONCOLOGY HOLDINGS INC. Director Ejecutivo 06/09/2023
Director Técnico/Científico/I+D 01/02/2015
Director Ejecutivo -
░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Jaume Pons.

Formación de Jaume Pons.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

92

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Sirpant Therapeutics